FABINO ENTERPRISES LIMITED Share Price

FABINO ENTERPRISES LIMITED Share Price

BSE: 543444
|
Pharmaceuticals
|
S Cap
₹ 20.31
+0.00 (0.00%)
1D
Last updated 27 Apr, 2026, 12:34 IST
--
0.00% up today
--
1D LOW
1D HIGH

FABINO ENTERPRISES LIMITED Returns Calculator

Circuit
L
H
₹19.30
₹21.32
52-week
L
H
₹13.01
₹27.00

About FABINO ENTERPRISES LIMITED

FABINO ENTERPRISES LIMITED Share Price
ISIN
INE0DRT01018
Sector Market Cap
₹ 4.27 Cr

Fabino Enterprises Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing, marketing, trading and packaging of pharmaceutical and other wellness-focused consumer products. Its core business is the marketing of pharmaceutical formulations and products in the domestic market through its own distribution network and sales force under its own brand name, getting its ayurvedic formulations manufactured through loan licensing facilities, packing, and labeling. It exports wellness and fast-moving consumer goods (FMCG) products, such as coffee, malt powder, protein powder, hair shampoo, which are marketed by its company. Its products include 21 No Tea, AMOXRAG-625, Astrid Syrup, Aur D3 Capsules, Aurceta AM, Aurcis-Forte, Aurifox OZ, Aurimor Gold, Aurimor plus, Aurirug 200, Aurirug O, Aurnim Plus, Aurstin 250, Aurstin 500, Aurzyme-Syrup, Ayush Kadha, Calogrip, Cefga 1gm, Cekal Forte, Ceporag O, Coptec Capsules, Coptec-syrup, Cough-Free, and Dexrog Syrup.

FABINO ENTERPRISES LIMITED Financial Highlights

  • Revenue: FABINO ENTERPRISES LIMITED reported revenue of ₹22.40 crore in FY26 vs ₹18.33 crore in FY25. It showed an increase of 22.20% on a yearly basis.
  • Operating Profit: FABINO ENTERPRISES LIMITED reported an operating loss of ₹0.74 crore in FY26 vs ₹0.19 crore in FY25. It showed a decrease of 489.47% on a year-on-year basis.
  • Net Profit: FABINO ENTERPRISES LIMITED reported a net loss of ₹0.56 crore in FY26 vs ₹0.06 crore in FY25. It showed a decrease of 1,033.33% on a yearly basis.
Know more
Promoters
56.82%
FII
0.00%
Other DII
0.00%
Retail and other
43.18%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20240.00%
Mar 20250.00%
Sep 20250.00%
Mar 20260.00%
Mkt Cap Cr
5.15
P/E
0.00
P/B
0.88
ROE
0.00%
D/E
0.33
ROCE
0.00%
Div. Yield
0.00%
EPS(TTM)
-1.71
Turnover
2.27
EV/EBITDA
0.00
Net Margin
-3.15%
Op. Margin
-2.10%
ROA
-10.63%
Quick Ratio
1.29
Curr. Ratio
1.51
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Fabino Enter outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Fabino Enter appears to be fairly valued compared to its peers
Step 2 of 5
Earnings
Poor
Fabino Enter earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

FABINO ENTERPRISES LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Revenue₹18.04₹21.08₹3.36
Other Income₹0.29₹0.01₹0.02
Total Revenue₹18.33₹21.09₹3.38
Total Expenses₹18.14₹21.04₹3.37
Profit Before Tax₹0.19₹0.05₹0.01
Tax₹0.13₹0.01₹0.00
Profit After Tax₹0.06₹0.04₹0.01
EPS - Basic₹0.29₹0.17₹0.05
EPS - Diluted₹0.29₹0.17₹0.05

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹0.74₹0.19₹0.04₹0.01
Income before WC changes-₹0.50₹0.40₹0.13₹0.05
Change in Assets-₹4.53-₹1.91-₹10.33-₹0.76
Change in Liabilities₹5.21₹1.76₹9.44₹0.04
Change in WC₹0.68-₹0.15-₹0.89-₹0.71
Cash flow from Operations₹0.19₹0.12-₹0.77-₹0.68
Cash flow from Investing₹0.07-₹0.29-₹0.28-₹0.01
Cash flow from Financing-₹0.30₹0.35₹0.86₹0.34
Total Cash Flow-₹0.05₹0.18-₹0.18-₹0.35
Cash (Start of the year)₹0.24₹0.06₹0.24₹0.59
Cash (End of the year)₹0.20₹0.24₹0.06₹0.24

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Non-Current Assets₹0.62₹0.43₹0.23
Current Assets₹17.03₹14.93₹4.78
Total Assets₹17.66₹15.36₹5.01
Current Liabilities₹11.66₹9.90₹0.45
Net Current Asset₹5.37₹5.03₹4.33
Non-Current Liabilities₹1.79₹1.31₹0.45
Equity Capital₹4.20₹4.14₹4.11
Total Equity & Liabilities₹17.66₹15.36₹5.01

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹18.04₹6.08₹3.36₹4.20
Other Income₹0.29₹0.29₹0.02₹0.01
Total Revenue₹18.32₹6.38₹3.38₹4.21
Total Expenses₹18.07₹6.32₹3.37₹4.15
Profit Before Tax₹0.26₹0.06₹0.01₹0.07
Tax₹0.13₹0.02₹0.00₹0.02
Profit After Tax₹0.13₹0.05₹0.01₹0.05
EPS - Basic₹0.63₹0.23₹0.05₹0.22
EPS - Diluted₹0.63₹0.23₹0.05₹0.22

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹0.48₹0.26₹0.05₹0.01
Income before WC changes-₹0.24₹0.45₹0.11₹0.05
Change in Assets-₹4.34-₹3.09-₹7.10-₹0.76
Change in Liabilities₹5.18₹2.64₹4.02₹0.04
Change in WC₹0.83-₹0.45-₹3.08-₹0.71
Cash flow from Operations₹0.59-₹0.12-₹2.99-₹0.68
Cash flow from Investing-₹0.01-₹0.29-₹0.18-₹0.01
Cash flow from Financing-₹0.63₹0.61₹0.43₹0.34
Total Cash Flow-₹0.05₹0.20-₹2.75-₹0.35
Cash (Start of the year)₹0.22₹0.02₹0.24₹0.59
Cash (End of the year)₹0.16₹0.22-₹2.50₹0.24

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹0.59₹0.37₹0.23₹0.27
Current Assets₹12.42₹9.13₹4.78₹4.36
Total Assets₹13.01₹9.50₹5.01₹4.62
Current Liabilities₹7.11₹4.46₹0.45₹0.41
Net Current Asset₹5.32₹4.66₹4.33₹3.95
Non-Current Liabilities₹1.61₹0.88₹0.45₹0.11
Equity Capital₹4.29₹4.16₹4.11₹4.10
Total Equity & Liabilities₹13.01₹9.50₹5.01₹4.62
* All values are in INR Crore
Qty
Bid
165000
21.32
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 165000
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
3
Neutral
1
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
ATR (14)
0.82
Neutral
STOCH(9,6)
100
Bearish
ADX(9)
100
Bearish
ROC(12)
47.71
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
18.48
18.61
10D
16.6
17.3
20D
15.28
15.99
50D
17.65
0
100D
17.65
0

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
FABINO ENTERPRISES LIMITED Share Price
FABINO ENTERPRISES LIMITED
Pharmaceuticals
Add Stock
Add Another

FABINO ENTERPRISES LIMITED Share Price FAQs

FABINO ENTERPRISES LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837